X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
analysis (2) 2
humans (2) 2
index medicus (2) 2
activated-protein-c (1) 1
addiction (1) 1
aged, 80 and over (1) 1
aging (1) 1
analgesics (1) 1
analgesics, opioid - administration & dosage (1) 1
b-domain (1) 1
blood coagulation - drug effects (1) 1
blood coagulation factors (1) 1
bortezomib (1) 1
carfilzomib (1) 1
comorbidity (1) 1
creatinine - blood (1) 1
critical care medicine (1) 1
daratumumab (1) 1
denmark - epidemiology (1) 1
dexamethasone (1) 1
drugs (1) 1
elotuzumab (1) 1
ema (1) 1
emergency medicine (1) 1
enzyme-linked immunosorbent assay (1) 1
european medicines agency (1) 1
factor viii (1) 1
factor viii - analysis (1) 1
factor viiia - analysis (1) 1
factor viiia - pharmacokinetics (1) 1
female (1) 1
fractures (1) 1
fviii (1) 1
fviii:c (1) 1
haemophilia a (1) 1
hematology (1) 1
hemophilia (1) 1
hemophilia a - blood (1) 1
hemophilia a - drug therapy (1) 1
hip fracture (1) 1
hip fractures - complications (1) 1
hip fractures - etiology (1) 1
hip fractures - mortality (1) 1
hospital mortality (1) 1
hospitalization - statistics & numerical data (1) 1
human factor-viii (1) 1
immunoglobulin g1 (1) 1
inactivation (1) 1
increases (1) 1
leukocytosis - mortality (1) 1
male (1) 1
management (1) 1
mechanisms (1) 1
medicine (1) 1
monotherapy (1) 1
mortality (1) 1
multiple myeloma (1) 1
neoplasms - mortality (1) 1
older-adults (1) 1
oncology (1) 1
opioids (1) 1
orthopedics (1) 1
osteoporosis - complications (1) 1
pain (1) 1
pain - drug therapy (1) 1
pain - etiology (1) 1
patient outcomes (1) 1
plasma (1) 1
postoperative period (1) 1
practice patterns, physicians' - statistics & numerical data (1) 1
prescription drug misuse - statistics & numerical data (1) 1
protein binding (1) 1
protein c (1) 1
rates (1) 1
recombinant proteins (1) 1
regulatory issues (1) 1
regulatory issues: ema (1) 1
risk (1) 1
risk factors (1) 1
surgery (1) 1
survival (1) 1
therapy (1) 1
thrombelastography (1) 1
thrombin - biosynthesis (1) 1
thrombin generation (1) 1
thromboelastography (1) 1
trends (1) 1
trial (1) 1
usage (1) 1
von willebrand factor - metabolism (1) 1
von-willebrand-factor (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Oncologist, ISSN 1083-7159, 05/2018, Volume 23, Issue 5, pp. 594 - 602
On May 20, 2016, a conditional marketing authorization valid through the European Union (EU) was issued for daratumumab as monotherapy for the treatment of... 
European Medicines Agency | Daratumumab | Multiple myeloma | SURVIVAL | TRIAL | DEXAMETHASONE | MONOTHERAPY | THERAPY | ONCOLOGY | BORTEZOMIB | EMA | Regulatory Issues
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.